Barclays Maintains Overweight on CME Gr, Raises Price Target to $230
Portfolio Pulse from jenniferd'souza@benzinga.com
Barclays analyst Jeremy Campbell maintains an Overweight rating on CME Group (NASDAQ:CME) and raises the price target from $215 to $230.
July 27, 2023 | 11:51 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays maintains an Overweight rating on CME Group and raises the price target from $215 to $230, which could lead to a positive market reaction.
The news of Barclays maintaining an Overweight rating and raising the price target for CME Group is likely to be seen as a positive signal by the market, potentially leading to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100